Medical Aesthetics Market

The global medical aesthetics market is projected to reach USD 25.9 billion by 2028 from USD 15.4 billion in 2023, at a CAGR of 11.0% from 2023 to 2028. The rising prevalence of targeted diseases and increasing technological advancements fuel the market growth.

The medical aesthetics market is moderately competitive, with established companies and upcoming competitors for the same market share. As of 2022, the key players operating in the global medical aesthetics market are Abbvie Inc (US), Galderma (Switzerland), Johnson & Johnson (US), Bausch Health Companies Inc. (Canada), and Cutera. (US) among others.

To know about the assumptions considered for the study download the pdf brochure

These competitors have utilized various strategies to increase their market share in the global medical aesthetics market, including acquisitions, agreements, partnerships, and product releases. In 2022, a higher share of the medical aesthetics market was held by Abbvie Inc. (US), Bausch Health Companies Inc. (Canada), and Johnson & Johnson (US).

Abbvie Inc. (US)

AbbVie is a global biopharmaceutical company with six product segments: Immunology, Hematologic Oncology, Aesthetics, Neuroscience, Eye Care, and Other Key Products. Their Aesthetics division provides a wide range of solutions, such as Botox Cosmetic, Juvederm Collection, and other aesthetic products, including facial injectables, regenerative medicine, body contouring, and skincare items.

Abbvie is among the leading companies in the global medical aesthetics market. A strong focus on research and innovation to discover and develop innovative pharmaceutical products with a diversified global presence are the company's major strengths and help in keeping its product pipeline robust.

Galderma (Switzerland):

Galderma is a leading global company in dermatology and skincare. They manufacture, market, and research dermatological treatments. They provide solutions for skin conditions like acne, psoriasis, rosacea, eczema, and fungal infections. Galderma operates in three segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology, offering medical aesthetic products in the Injectable Aesthetics segment.

Galderma is one of the leading dermatological companies that delivers novel facial injectables globally. The company is focused on R&D, innovation, and significant brand recognition. Robust manufacturing capabilities enable Galderma to provide high-quality aesthetic solutions, giving the company a competitive position in the market.

Johnson & Johnson (US)

Johnson & Johnson (J&J) is a prominent player in the healthcare industry, engaged in the development, manufacturing, and marketing of a diverse range of products. The company operates across three major business sectors: Consumer Health, Pharmaceutical, and MedTech. In the MedTech segment, J&J offers medical aesthetic products. In January 2009, J&J acquired Mentor Worldwide LLC, which now functions as a distinct business unit under Ethicon, Inc. Mentor has been serving J&J's medical aesthetics business since the acquisition.

Mentor Worldwide LLC, a subsidiary of Johnson & Johnson, is a prominent presence in the breast implants sector of the medical aesthetics market. With a substantial presence in Europe, Asia, Latin America, and North America, the company is committed to bolstering its market position primarily through organic means. This includes initiatives like introducing new products and expanding customer service offerings. In addition to product launches, Mentor also prioritizes forming agreements and partnerships with key industry players to broaden its range of products.

Related Reports:

Medical Aesthetics Market by Product (Botox, Filler, Peel, Implant, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Nonsurgical), End User (Hospital, Beauty Clinic, Spa), Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]